Cirillo M, Federico M, Curci G, Tamborrino E, Piccinini L, Silingardi V
Cattedra e Divisione di Oncologia Medica, Università di Modena, Italy.
Haematologica. 1992 Mar-Apr;77(2):156-61.
Primary non Hodgkin's lymphoma (NHL) of the gastrointestinal tract (GI) is the most frequent extranodal lymphoma accounting for approximately 40% of all extranodal primary NHL. The role of surgery and other treatment modalities in the management of these patients is still controversial.
We reviewed the records of 68 patients with primary GI-NHL. Ten patients had incomplete records and were excluded from further evaluation. The records of 58 patients were considered, and all were available for analysis and follow-up.
The most frequent site of involvement was the stomach (47 patients), followed by ileum (7 patients), large bowel (3 patients) and duodenum (1 patient). Malignant lymphomas of follicular center cell origin represented the most prevalent histologic types, accounting for 58% (34 of 58) of all cases. Stage, evaluated according to the criteria of Musshoff, was Ie in 15 cases, IIe in 16, IIIe in 7, and IV in the remaining 20 cases. The median survival for the entire group of 58 patients was 54 months, with 46% of patients surviving at 5 years. The median survival was 71 months for patients in stage I-II, 60 for patients in stage III, and 25 for patients in stage IV (p = 0.016). Moreover, we found significantly improved survival in patients undergoing surgical tumor resection (p = 0.003).
Even if at the present time the optimal management of primary GI-NHL is difficult to assess, our data suggest that it is prudent to advise resection followed by adjuvant CT in most patients, whereas CT alone should be considered only when surgery cannot be performed.
原发性胃肠道非霍奇金淋巴瘤(NHL)是最常见的结外淋巴瘤,约占所有原发性结外NHL的40%。手术及其他治疗方式在这些患者管理中的作用仍存在争议。
我们回顾了68例原发性胃肠道NHL患者的记录。10例患者记录不完整,被排除在进一步评估之外。考虑了58例患者的记录,所有这些记录都可用于分析和随访。
最常受累部位是胃(47例患者),其次是回肠(7例)、大肠(3例)和十二指肠(1例)。滤泡中心细胞起源的恶性淋巴瘤是最常见的组织学类型,占所有病例的58%(58例中的34例)。根据Musshoff标准评估的分期,Ie期15例,IIe期16例,IIIe期7例,其余20例为IV期。58例患者的中位生存期为54个月,5年生存率为46%。I-II期患者的中位生存期为71个月,III期患者为60个月,IV期患者为25个月(p = 0.016)。此外,我们发现接受手术肿瘤切除的患者生存率显著提高(p = 0.003)。
即使目前原发性胃肠道NHL的最佳管理难以评估,但我们的数据表明,在大多数患者中建议先进行切除然后辅助化疗是谨慎的做法,而仅在无法进行手术时才应考虑单纯化疗。